170 related articles for article (PubMed ID: 34697154)
1. Kallikrein 11 Down-regulation in Breast Carcinoma: Correlation With Prognostic Parameters.
Ozturk T; Kain EZ; Tuzuner MB; Diren A; Batur S; Yilmaz-Aydogan H; Ozturk O; Isbir T
In Vivo; 2021; 35(6):3233-3243. PubMed ID: 34697154
[TBL] [Abstract][Full Text] [Related]
2. Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer.
Bi X; He H; Ye Y; Dai Q; Han Z; Liang Y; Zhong W
Med Oncol; 2010 Mar; 27(1):145-51. PubMed ID: 19242826
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.
Stavropoulou P; Gregorakis AK; Plebani M; Scorilas A
Clin Chim Acta; 2005 Jul; 357(2):190-5. PubMed ID: 15893744
[TBL] [Abstract][Full Text] [Related]
4. Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.
Shigemasa K; Gu L; Tanimoto H; O'Brien TJ; Ohama K
Clin Cancer Res; 2004 Apr; 10(8):2766-70. PubMed ID: 15102682
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3.
Sano A; Sangai T; Maeda H; Nakamura M; Hasebe T; Ochiai A
Int J Oncol; 2007 Jun; 30(6):1493-8. PubMed ID: 17487371
[TBL] [Abstract][Full Text] [Related]
6. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
Ehrenfeld P; Manso L; Pavicic MF; Matus CE; Borquez C; Lizama A; Sarmiento J; Poblete MT; Bhoola KD; Naran A; Figueroa CD
Anticancer Res; 2014 Dec; 34(12):6925-38. PubMed ID: 25503118
[TBL] [Abstract][Full Text] [Related]
7. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
Borgoño CA; Fracchioli S; Yousef GM; Rigault de la Longrais IA; Luo LY; Soosaipillai A; Puopolo M; Grass L; Scorilas A; Diamandis EP; Katsaros D
Int J Cancer; 2003 Sep; 106(4):605-610. PubMed ID: 12845660
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer.
Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM
Tumour Biol; 2016 Jan; 37(1):437-46. PubMed ID: 26224476
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer.
Patsis C; Yiotakis I; Scorilas A
Clin Biochem; 2012 Jun; 45(9):623-30. PubMed ID: 22429520
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues.
Yousef GM; Chang A; Diamandis EP
J Biol Chem; 2000 Apr; 275(16):11891-8. PubMed ID: 10766816
[TBL] [Abstract][Full Text] [Related]
13. Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Planque C; Aïnciburu M; Heuzé-Vourc'h N; Régina S; de Monte M; Courty Y
Biol Chem; 2006 Jun; 387(6):783-8. PubMed ID: 16800740
[TBL] [Abstract][Full Text] [Related]
14. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.
Talieri M; Devetzi M; Scorilas A; Pappa E; Tsapralis N; Missitzis I; Ardavanis A
Tumour Biol; 2012 Aug; 33(4):1075-84. PubMed ID: 22351561
[TBL] [Abstract][Full Text] [Related]
15. KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients.
Alexopoulou DK; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Biomark Med; 2014; 8(5):671-85. PubMed ID: 25123036
[TBL] [Abstract][Full Text] [Related]
16. Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.
Paliouras M; Diamandis EP
Tumour Biol; 2008; 29(2):63-75. PubMed ID: 18515984
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression of Kallikreins in Breast Cancer Cell Lines.
Watrowski R; Castillo-Tong DC; Obermayr E; Zeillinger R
Anticancer Res; 2020 May; 40(5):2487-2495. PubMed ID: 32366393
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer.
Planque C; Choi YH; Guyetant S; Heuzé-Vourc'h N; Briollais L; Courty Y
Clin Chem; 2010 Jun; 56(6):987-97. PubMed ID: 20360129
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients.
Jamaspishvili T; Scorilas A; Kral M; Khomeriki I; Kurfurstova D; Kolar Z; Bouchal J
Neoplasma; 2011; 58(4):298-303. PubMed ID: 21520985
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
